- First commercial shipment for Australian medical cannabis market
- TGOD’s organic portfolio provides patients with consistent and reliable products
- TGOD continues to execute its international growth strategy
TORONTO, Oct. 19, 2021 /CNW/ – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD“) (CSE: TGOD) (OTC: TGODF), a leading producer of premium certified organically grown cannabis, is pleased to announce it completed its first commercial shipment consisting of cannabis oils destined for the Australian medical cannabis market.
Medicinal cannabis was federally legalized in Australia in 2016. In 2020, TGOD signed a distribution agreement with LeafCann for the Australian and New Zealand medical cannabis markets. The TGOD organic products portfolio provides health practitioners with a safe alternative for patients who rely on quality products that are certified organically grown. As shown by intensive stability studies conducted by LeafCann and TGOD, the TGOD oils are reliable in their consistency and maintain their cannabinoid content. The Company expects to introduce more cannabis products to the Australian and New Zealand markets in 2022.
“This shipment to Australia is an important milestone for TGOD as it marks our entry into the Asia-Pacific market” said Sean Bovingdon, TGOD’s CEO and Interim CFO. Coming less than two months after its first shipment to South Africa, TGOD continues to lay the foundation for large-scale international market commercialization. “We remain laser-focused on execution as we chart the course for future growth, including opportunities in international markets,” added Bovingdon.
“LeafCann is excited to be executing on its strategy to provide high-quality products at affordable prices into the Australian market. The Green Organic Dutchman’s commitment to organic production is a real plus and a clear point of differentiation in the marketplace,” said LeafCann CEO, Elisabetta Faenza.